- Home
- TNDM
as 08-01-2025 4:00pm EST
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Upcoming Earnings Alert:
Get ready for potential market movements as Tandem Diabetes Care Inc. TNDM prepares to release earnings report on 06 Aug 2025.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | 1.1B | IPO Year: | 2013 |
| Target Price: | $32.15 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.31 - $47.60 | Next Earning Date: | 08-06-2025 |
| Revenue: | $982,951,000 | Revenue Growth: | 27.65% |
| Revenue Growth (this year): | 8.91% | Revenue Growth (next year): | 10.94% |
Latest Tandem Diabetes Care Inc. News
TNDM Breaking Stock News: Dive into TNDM Ticker-Specific Updates for Smart Investing
TipRanks
a month ago
Diabetes stocks rally after RFK comments on HHS campaign
MedTech Dive
a month ago
Tandem’s Elizabeth Gasser on patch pump plans, Abbott partnership
StockStory
a month ago
The 5 Most Interesting Analyst Questions From Tandem Diabetes’s Q1 Earnings Call
Argus Research
a month ago
TNDM: What does Argus have to say about TNDM?
MedTech Dive
a month ago
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors
Zacks
a month ago
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 +
Medical Device Network
a month ago
Tandem’s t:slim X2 pump now works with Abbott’s FreeStyle CGM sensor
Business Wire
a month ago
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
Compare TNDM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.